Don't Just Read the News, Understand It.
Published loading...Updated

The race for the next Ozempic is on

  • The study published in the journal Nature Medicine found that GLP-1 drugs can reduce the risk of kidney disease but increase the risk of kidney stones.
  • Research indicated that GLP-1 medications may lead to lower risks of Alzheimer's disease and heart disease, but also pose risks such as pancreatitis and nausea.
  • Dr. Ziyad Al-Aly noted that GLP-1s could help curb addictions, including smoking, by suppressing appetite through brain mechanisms.
  • Physicians warn against using GLP-1 medications for conditions beyond diabetes and obesity until further clinical trials confirm their safety and efficacy.
Insights by Ground AI
Does this summary seem wrong?

23 Articles

All
Left
3
Center
6
Right
6
The Washington HispanicThe Washington Hispanic
Reposted by
udgtvudgtv
Center

Having demonstrated its effectiveness against obesity, do GLP-1 drugs keep other surprises for users? Recent studies show promising advances in the face of a huge panel of diseases, from Alzheimer’s syndrome to cardiovascular pathologies, but experts warn that they should not be seen as miracle molecules. They are known by the names of Ozempic, Wegovy, Mounjaro... They appeared about a decade ago, first as remedies against diabetes and, recently…

·Washington, United States
Read Full Article
Lean Right

Two new studies indicate that people who take medications containing the substance Semaglutide – which is found in the popular diabetes medication Ozempic, among other things – are at an increased risk of developing the eye disease Naion. The European Medicines Agency's Safety Committee PRAC has therefore begun a review of medications such as Ozempic, the Swedish Medicines Agency writes...

·Stockholm, Sweden
Read Full Article
Right

Now, according to American research, it appears that slimming injections can solve dozens of health problems such as cardiovascular diseases and dementia. But beware: they can also cause other ailments.

·Amsterdam, Netherlands
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources are Center, 40% of the sources lean Right
40% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

udgtv broke the news in on Monday, January 20, 2025.
Sources are mostly out of (0)